A Phase I Study of CS1002 in Subjects With Advanced Solid Tumors
Clinical trial NCT04338724 · COMPLETED
Trial details
- NCT number
- NCT04338724
- Sponsor
- CStone Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-27
- Primary completion
- 2020-09-21
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.